Big pharma turns to small biotechs for edge in cancer treatment
Partnerships between big pharma and small biotech companies have highlighted the scramble for assets in a new category of medicines billed as the most important breakthrough against cancer for decades. Novartis of Switzerland, Merck of the US and its German namesake Merck Serono have all forged alliances in recent days aimed at strengthening their position […]
